We are live on ! Find out more
ECM

Everence Capital Management Portfolio holdings

AUM $1.64B
1-Year Est. Return 26.46%
This Fund
S&P 500
This Quarter Est. Return
+5.85%
1 Year Est. Return
+26.46%
3 Year Est. Return
+80.44%
5 Year Est. Return
+106.59%
10 Year Est. Return
+436.91%
AUM
$270M
AUM Growth
+$16M
Cap. Flow
+$2.67M
Cap. Flow %
0.99%
Top 10 Hldgs %
18.47%
Holding
276
New
10
Increased
19
Reduced
6
Closed
5

Top Buys

Rank Stock Value
1
GM icon
General Motors
GM
+$427K
2
VZ icon
Verizon
VZ
+$325K
3
LLY icon
Eli Lilly
LLY
+$229K
4
EW icon
Edwards Lifesciences
EW
+$213K
5
CTXS
Citrix Systems Inc
CTXS
+$208K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$707K
2
FRX
FOREST LABORATORIES INC
FRX
+$420K
3
WFM
Whole Foods Market Inc
WFM
+$250K
4
NBR icon
Nabors Industries
NBR
+$247K
5
NVDA icon
NVIDIA
NVDA
+$211K

Sector Composition

Rank Sector Weight
1 Technology 16.94%
2 Financials 15.92%
3 Healthcare 14.21%
4 Communication Services 10.2%
5 Energy 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CME icon
201
CME Group
CME
$95.4B
$372K 0.14%
5,240
– –
M icon
202
Macy's
M
$6.51B
$354K 0.13%
6,103
– –
ADM icon
203
Archer Daniels Midland
ADM
$38.7B
$346K 0.13%
7,850
– –
EIX icon
204
Edison International
EIX
$30.3B
$344K 0.13%
5,917
– –
AMAT icon
205
Applied Materials
AMAT
$347B
$342K 0.13%
15,187
– –
A icon
206
Agilent Technologies
A
$39.6B
$332K 0.12%
8,087
– –
FISV
207
Fiserv Inc
FISV
$29.7B
$326K 0.12%
10,800
– –
WHR icon
208
Whirlpool
WHR
$2.49B
$318K 0.12%
2,283
– –
DOV icon
209
Dover
DOV
$26.7B
$317K 0.12%
4,312
– –
CCL icon
210
Carnival Corporation Ltd
CCL
$38.1B
$316K 0.12%
8,393
– –
MPC icon
211
Marathon Petroleum
MPC
$90.1B
$311K 0.12%
7,956
– –
AKAM icon
212
Akamai
AKAM
$15.6B
$310K 0.12%
5,069
– –
DVA icon
213
DaVita
DVA
$15.5B
$310K 0.12%
4,292
– –
MCK icon
214
McKesson
MCK
$104B
$310K 0.12%
1,664
– –
MRSH
215
Marsh
MRSH
$94.3B
$307K 0.11%
5,930
– –
NEM icon
216
Newmont
NEM
$96.2B
$306K 0.11%
12,040
– –
RHI icon
217
Robert Half
RHI
$4.11B
$302K 0.11%
6,317
– –
ROST icon
218
Ross Stores
ROST
$80.8B
$302K 0.11%
9,142
– –
HOG icon
219
Harley-Davidson
HOG
$2.61B
$301K 0.11%
4,305
– –
ZBH icon
220
Zimmer Biomet
ZBH
$18.8B
$300K 0.11%
2,973
– –
FITB
221
Fifth Third Bancorp
FITB
$51.3B
$298K 0.11%
13,966
– –
ORLY icon
222
O'Reilly Automotive
ORLY
$75.1B
$296K 0.11%
29,445
– –
IP icon
223
International Paper
IP
$22.6B
$292K 0.11%
6,190
– –
SRE icon
224
Sempra
SRE
$58.1B
$285K 0.11%
5,446
– –
XEL icon
225
Xcel Energy
XEL
$49.2B
$283K 0.11%
8,784
– –
7 8
9
10 11

Similar funds

LIA
LBMC Investment Advisors Brentwood, Tennessee $1.64B AUM 15.26% 1-Year Est. Return
GA
Greenspring Advisors Towson, Maryland $1.64B AUM
AHC
Adell Harriman & Carpenter Houston, Texas $1.64B AUM 36.77% 1-Year Est. Return
UMC
UNC Management Company Chapel Hill, North Carolina $1.64B AUM 17.65% 1-Year Est. Return
1SP
140 Summer Partners New York $1.64B AUM 47.44% 1-Year Est. Return
MRG
Milestone Resources Group Road Town Tortola, British Virgin Islands $1.64B AUM 7.52% 1-Year Est. Return
TIAA Trust, National Association
TIAA Trust, National Association Charlotte, North Carolina $1.65B AUM 16.63% 1-Year Est. Return
TCA
Troluce Capital Advisors Dorado, Puerto Rico $1.63B AUM 37.23% 1-Year Est. Return

Everence Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Everence Capital Management held 276 positions worth $270M, up 6.3% from $254M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Everence Capital Management's Q2 2014 filing shows 10 new, 19 increased, 6 reduced and 5 closed positions. Its largest new stake was Edwards Lifesciences: 15,720 shares worth $225K. The largest sale was Celgene Corp, an estimated $707K.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Everence Capital Management's largest Q2 2014 buy was Edwards Lifesciences: 15,720 shares worth $225K.
  • Everence Capital Management added most to General Motors in Q2 2014, an estimated $427K increase.
  • Everence Capital Management's biggest Q2 2014 reduction was Celgene Corp, cutting an estimated $707K.
  • Everence Capital Management fully exited FOREST LABORATORIES INC in Q2 2014, selling an estimated $420K.
  • Everence Capital Management's ten largest holdings make up 18% of its $270M portfolio in Q2 2014.
  • Everence Capital Management opened 10 new positions and closed 5 in Q2 2014.
  • Everence Capital Management's portfolio value rose 6.3% quarter-over-quarter to $270M.

Based on Everence Capital Management's 13F filing for Q2 2014, filed 4 Aug 2014.